Improved Outcomes in Early Clinical Development, created and developed by IIR, brings together pharmaceutical executives, entrepreneurial scientists and venture capitalists to improve outcomes with advancements in tools and techniques and leveraging early clinical development for partnerships and investments. The event is structured for Pharmaceutical & Biotech Manufacturers in early stage development working in Biostatistics, Clinical Pharmacology, Drug Discovery, Early Drug Development, Experimental Medicine, Exploratory Medicine, Phase I Studies, PK/PD and Translational Medicine.